Astrana Health Inc (ASTH)
Return on equity (ROE)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 43,149 | 60,717 | 45,171 | 68,923 | -23,752 |
| Total stockholders’ equity | US$ in thousands | 712,720 | 614,218 | 542,561 | 448,167 | 330,824 |
| ROE | 6.05% | 9.89% | 8.33% | 15.38% | -7.18% |
December 31, 2024 calculation
ROE = Net income ÷ Total stockholders’ equity
= $43,149K ÷ $712,720K
= 6.05%
Astrana Health Inc's Return on Equity (ROE) has shown fluctuations over the years based on the provided data.
- In December 31, 2020, the ROE stood at -7.18%, indicating that the company's net income did not generate a positive return relative to its shareholders' equity.
- By December 31, 2021, there was a significant improvement in ROE, reaching 15.38%. This suggests that the company was able to generate a positive return for its shareholders, indicating better profitability and efficiency in the utilization of equity.
- In the following years, the ROE continued to show some variations: 8.33% by December 31, 2022, 9.89% by December 31, 2023, and 6.05% by December 31, 2024. These fluctuations suggest some volatility in the company's profitability and efficiency in using equity to generate returns.
Overall, it is essential for Astrana Health Inc to monitor and analyze the factors influencing its ROE to sustain positive returns and ensure effective use of equity to create value for its shareholders.
Peer comparison
Dec 31, 2024